These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2547110)

  • 21. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits].
    Denis P; Dussaillant M; Elena PP; Nordmann JP; Rostene W; Laroche L
    Ophtalmologie; 1990; 4(1):30-2. PubMed ID: 2174530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACh- and VIP-induced vasorelaxation in rabbit facial artery after carotid artery occlusion.
    Roganović J; Radenković M; Stojić D
    Arch Oral Biol; 2010 May; 55(5):333-42. PubMed ID: 20359690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of alpha1-adrenoceptor subtypes in rabbit aorta and arteries: regional difference and co-existence.
    Satoh M; Enomoto K; Takayanagi I; Koike K
    Eur J Pharmacol; 1999 Jun; 374(2):229-40. PubMed ID: 10422764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation.
    Duckles SP; Said SI
    Eur J Pharmacol; 1982 Mar; 78(3):371-4. PubMed ID: 6121712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glibenclamide does not block arterial relaxation caused by vasoactive intestinal polypeptide.
    Hattori Y; Nagashima M; Endo Y; Kanno M
    Eur J Pharmacol; 1992 Mar; 213(1):147-50. PubMed ID: 1499652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
    Martin JL; Dietl MM; Hof PR; Palacios JM; Magistretti PJ
    Neuroscience; 1987 Nov; 23(2):539-65. PubMed ID: 3437978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of experimental subarachnoid hemorrhage on the relaxation induced by vasoactive intestinal polypeptide in the cerebral arteries of the rabbit.
    Tsukahara T; Hongo K; Kassell NF; Ogawa H
    Neurosurgery; 1989 May; 24(5):731-5. PubMed ID: 2541369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals.
    Edvinsson L; Fahrenkrug J; Hanko J; Owman C; Sundler F; Uddman R
    Cell Tissue Res; 1980; 208(1):135-42. PubMed ID: 6771016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy does not alter the response of uterine arteries to vasoactive intestinal polypeptide.
    Jovanovic S; Grbovic L; Jovanovic A
    Mol Hum Reprod; 2000 Apr; 6(4):361-8. PubMed ID: 10729319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effect of endothelium on the responses to sumatriptan in rabbit isolated iliac, mesenteric and carotid arteries.
    Yildiz O; Tuncer M
    Arch Int Pharmacodyn Ther; 1994; 328(2):200-12. PubMed ID: 7710305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of endothelin by vascular smooth muscle cells.
    Kanse SM; Takahashi K; Warren JB; Perera T; Porta M; Ghatei M; Bloom SR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S113-6. PubMed ID: 1725301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S; Rattan S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events.
    Hill JM; Agoston DV; Gressens P; McCune SK
    J Comp Neurol; 1994 Apr; 342(2):186-205. PubMed ID: 8201031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration.
    Ohmori Y; Onoue S; Endo K; Matsumoto A; Uchida S; Yamada S
    Life Sci; 2006 Jun; 79(2):138-43. PubMed ID: 16458931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.
    Erdling A; Sheykhzade M; Maddahi A; Bari F; Edvinsson L
    Neuropeptides; 2013 Apr; 47(2):85-92. PubMed ID: 23375386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier.
    Jia L; Stamler JS
    Eur J Pharmacol; 1999 Jan; 366(1):79-86. PubMed ID: 10064155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.
    Reubi JC
    J Nucl Med; 1995 Oct; 36(10):1846-53. PubMed ID: 7562054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of neurotensin receptors with VIP-containing neurons and serotonin-containing axons in the suprachiasmatic nucleus of the rat.
    François-Bellan AM; Bosler O; Tonon MC; Wei LT; Beaudet A
    Synapse; 1992 Apr; 10(4):282-90. PubMed ID: 1316637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies.
    Pallela VR; Thakur ML; Chakder S; Rattan S
    J Nucl Med; 1999 Feb; 40(2):352-60. PubMed ID: 10025846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.